Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Increased Expression of the Sialyltransferase Gene ST3GAL1 Predicts Lack of Sustained MRD Negativity and Increased Risk of Progression in Newly Diagnosed, Transplant Eligible Multiple Myeloma Patients in the Maintenance/Observation Phase of Cassiopeia Study

Michael O'Dwyer, Aideen Edele Ryan, Aoise O'Neill, Catherine Guerin-Charbonnel, Soraya Wuilleme, Jill Corre, Herve Avet Loiseau, Li Peng, Philippe Moreau, Stephane Minvielle

Blood (2024) 144 (Supplement 1): 250.

https://doi.org/10.1182/blood-2024-193955

Published: 2024

Journal Articles

Artificial Intelligence Using Multimodal Data for Myelodysplastic Syndrome Screening

Cedric De almeida Braga, Maxence Bauvais, Maxence Dominici, Alice Garnier, Pierre Peterlin, Camille Debord, Soraya Wuillème, Olivier Theisen, Catherine Godon, Simon Bouzy, Yannick Le Bris, Marie C Bene, Patrice Chevallier, Nicolas Normand, Marion Eveillard

Blood (2022) 140 (Supplement 1): 9800–9801.

https://doi.org/10.1182/blood-2022-166979

Published: 2022

Journal Articles

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

Murielle Roussel, Valérie Lauwers-Cances, Margaret Macro, Xavier Leleu, Bruno Royer, Cyrille Hulin, Lionel Karlin, Aurore Perrot, Cyrille Touzeau, Marie-Lorraine Chrétien, Sophie Rigaudeau, Mamoun Dib, Emmanuelle Nicolas-Virelizier, Martine Escoffre-Barbe, Karim Belhadj, Clara Mariette, Anne-Marie Stoppa, Carla Araujo, Chantal Doyen, Jean Fontan, Brigitte Kolb, Laurent Garderet, Sabine Brechignac, Jean-Valère Malfuson, Arnaud Jaccard, Pascal Lenain, Cécile Borel, Benjamin Hebraud, Omar Benbrahim, Véronique Dorvaux, Salomon Manier, Karine Augeul-Meunier, Marie-Christiane Vekemans, Edouard Randriamalala, Driss Chaoui, Jo Caers, Carine Chaleteix, Lofti Benboubker, Laure Vincent, Sylvie Glaisner, Patricia Zunic, Borhane Slama, Jean-Richard Eveillard, Catherine Humbrecht-Kraut, Véronique Morel, Philippe Mineur, Jean-Claude Eisenmann, Hélène Demarquette, Valentine Richez, Marguerite Vignon, Denis Caillot, Thierry Facon, Philippe Moreau, Anne-Laurène Colin, Pascale Olivier, Soraya Wuilleme, Hervé Avet-Loiseau, Jill Corre, Michel Attal

Blood (2022) 139 (18): 2747–2757.

https://doi.org/10.1182/blood.2021014635

Published: 2022

Includes: Supplemental data

Journal Articles

Peripheral Levels of Monocytic Myeloid-Derived Suppressive Cells at Diagnosis Predict Survivals in AML Patients Eligible for Intensive Chemotherapy

Blood (2021) 138 (Supplement 1): 3465.

https://doi.org/10.1182/blood-2021-149405

Published: 2021

Journal Articles

Daratumumab (DARA) with Bortezomib, Thalidomide, and Dexamethasone (VTd) in Transplant-Eligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) Negativity in Cassiopeia Part 1 and Part 2

Blood (2021) 138 (Supplement 1): 82.

https://doi.org/10.1182/blood-2021-147897

Published: 2021

Journal Articles

Up-front carfilzomib, lenalidomide, and dexamethasone with transplant for patients with multiple myeloma: the IFM KRd final results

Murielle Roussel, Valerie Lauwers-Cances, Soraya Wuilleme, Karim Belhadj, Salomon Manier, Laurent Garderet, Martine Escoffre-Barbe, Clara Mariette, Lotfi Benboubker, Denis Caillot, Cécile Sonntag, Cyrille Touzeau, Jehan Dupuis, Philippe Moreau, Xavier Leleu, Thierry Facon, Benjamin Hébraud, Jill Corre, Michel Attal

Blood (2021) 138 (2): 113–121.

https://doi.org/10.1182/blood.2021010744

Published: 2021

Journal Articles

Multicentric Real Life Evaluation of the Impact of Next-Generation Sequencing on the Clinical Management of Chronic Myeloid Malignancies

Blood (2019) 134 (Supplement_1): 5771.

https://doi.org/10.1182/blood-2019-122958

Published: 2019

Journal Articles

Comparison of the Performance of Surface Alone or Surface Plus Cytoplasmic Approaches for the Assessment of Minimal Residual Disease in Multiparameter Flow Cytometry in Multiple Myeloma

Marie C Bene, PharmD,DPhil, Nelly Robillard, PhD, Philippe Moreau, MD, Soraya Wuilleme, PharmD, PhD

Blood (2019) 134 (Supplement_1): 1799.

https://doi.org/10.1182/blood-2019-130607

Published: 2019

Journal Articles

Profound Lymphopenia at the Time of ATG Administration Is Not Predictive of Survivals after Allotransplant Using Purine Analogue/Busulfan-Based Conditioning Regimen

Blood (2019) 134 (Supplement_1): 1985.

https://doi.org/10.1182/blood-2019-122013

Published: 2019

Journal Articles

A New Cytokine-Based Stratification Is Highly Predictive of Survivals in AML Patients

Blood (2019) 134 (Supplement_1): 1412.

https://doi.org/10.1182/blood-2019-125774

Published: 2019

Journal Articles

Prognostic Value of Lymphopenia and Lymphocytosis after Peripheral Blood Haplo-Identical Stem Cell Transplantation

Yannick LE Bris, PharmD, Thierry Guillaume, MD PhD, Camille Debord, PharmD, Pierre Peterlin, Soraya Wuilleme, PharmD, PhD, Céline Bressollette, MD PhD, Amandine Le Bourgeois, MD, Alice Garnier, MD, Aurélie Fantou, PharmD, Marie Audrain, MD PhD, Audrey Ménard, Nelly Robillard, PhD, Marion Eveillard, Steven Le Gouill, Berthe Marie Imbert, PharmD, PhD, Marie C Bene, PharmSciD, PhD, Patrice Chevallier, MD

Blood (2019) 134 (Supplement_1): 3319.

https://doi.org/10.1182/blood-2019-122093

Published: 2019

Journal Articles

Fms-like Tyrosine Kinase 3 Ligand Concentration Kinetic Profile during Induction Is Strongly Predictive of Survivals in AML: Results of the FLAM/Flal Study

Blood (2018) 132 (Supplement 1): 1484.

https://doi.org/10.1182/blood-2018-99-111694

Published: 2018

Journal Articles

CD38 Expression in B-Lineage Acute Lymphoblastic Leukemia, a Possible Target for Immunotherapy

Marion Eveillard, PharmD, PhD, Victor Floc'h, Nelly Robillard, PhD, Camille Debord, Soraya Wuilleme, PharmD, PhD, Richard Garand, Fanny Rialland, MD, Caroline Thomas, Pierre Peterlin, MD, Thierry Guillaume, MD PhD, Philippe Moreau, Patrice Chevallier, MD PhD, Marie C Bene, PharmSciD, PhD

Blood (2016) 128 (22): 5268.

https://doi.org/10.1182/blood.V128.22.5268.5268

Published: 2016

Journal Articles

Expansion of T or B Lymphocytes after Unrelated Cord Blood (UCB) Allogeneic Stem Cell Transplantation in Adults Correlates with CMV Reactivation and Is Associated with a Better Outcome

Yannick Le Bris, PharmD, Thierry Guillaume, MD PhD, Marina Iliaquer, PharmD, Jerome Martin, PharmD, PhD, Pierre Peterlin, MD, Audrey Menard, Marion Eveillard, PharmD, Soraya Wuilleme, PharmD, PhD, Nelly Robillard, PhD, Jacques Delaunay, MD, Mohamad Mohty, MD PhD, Alice Garnier, MD, Philippe Moreau, MD PhD, Marie C Bene, PharmSciD, PhD, Patrice Chevallier, MD PhD

Blood (2015) 126 (23): 1947.

https://doi.org/10.1182/blood.V126.23.1947.1947

Published: 2015

Journal Articles

Misleading acute promyelocytic leukemia morphology

Soraya Wuillème, Yannick Le Bris

Blood (2015) 125 (24): 3815.

https://doi.org/10.1182/blood-2015-02-616904

Published: 2015

Journal Articles

Relative Stability Of Plasma Cells Immunophenotype In Multiple Myeloma Over Time

Benoit Tessoulin, Steven Legouill, MD PhD, Marion Eveillard, Nelly Robillard, Soraya Wuilleme, Thomas Gastinne, MD, Cyrille Touzeau, MD, Catherine Pellat-Deceunynck, PhD, Marie C Bene, PharmSciD, PhD, Philippe Moreau, MD

Blood (2013) 122 (21): 1885.

https://doi.org/10.1182/blood.V122.21.1885.1885

Published: 2013

Journal Articles

Cereblon (CRBN) Splicing Could Influence Response To IMiDs : A New PCR Strategy to Easily Detect and Semi-Quantify Loss Of The IMiDs Binding Domain

Blood (2013) 122 (21): 3107.

https://doi.org/10.1182/blood.V122.21.3107.3107

Published: 2013

Journal Articles

Paired Immunophenotype Comparison Of Diagnosis and Relapse Samples In B-Lineage Acute Lymphoblastic Leukemia

Marion Eveillard, Richard Garand, MD, Nelly Robillard, Soraya Wuilleme, MD, PhD, Caroline Thomas, M.D., Marion Strullu, Fanny Rialland, M.D., Jacques Delaunay, MD, Patrice Chevallier, MD, PhD, Philippe Moreau, MD, Nicolas Blin, Marie-Christine Bene, PharmSciD, PhD

Blood (2013) 122 (21): 4954.

https://doi.org/10.1182/blood.V122.21.4954.4954

Published: 2013

Journal Articles

Backtracking Subclonal Mutations Of TP53 In Myelodysplasia (MDS) With Del(5q) With Next-Generation Sequencing (NGS)

Blood (2013) 122 (21): 520.

https://doi.org/10.1182/blood.V122.21.520.520

Published: 2013

Journal Articles

Bortezomib, Lenalidomide, and Dexamethasone (VRD) Consolidation and Lenalidomide Maintenance in Frontline Multiple Myeloma Patients: Updated Results of the IFM 2008 Phase II VRD Intensive Program

Murielle Roussel, Nelly Robillard, Philippe Moreau, MD, Lotfi Benboubker, MD, PhD, Cyrille Hulin, MD, Gerald Marit, MD, PhD, Xavier Leleu, MD, PhD, Brigitte Pegourie, MD, Christophe Fruchart, MD, Denis Caillot, MD, Anne-Marie Stoppa, MD, Thierry Facon, MD, Soraya Wuilleme, MD, PhD, Hervé Avet-Loiseau, MD, PhD, Michel Attal, MD

Blood (2011) 118 (21): 1872.

https://doi.org/10.1182/blood.V118.21.1872.1872

Published: 2011

NARROW

Increased Expression of the Sialyltransferase Gene ST3GAL1 Predicts Lack of Sustained MRD Negativity and Increased Risk of Progression in Newly Diagnosed, Transplant Eligible Multiple Myeloma Patients in the Maintenance/Observation Phase of Cassiopeia Study

Artificial Intelligence Using Multimodal Data for Myelodysplastic Syndrome Screening

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

Peripheral Levels of Monocytic Myeloid-Derived Suppressive Cells at Diagnosis Predict Survivals in AML Patients Eligible for Intensive Chemotherapy

Daratumumab (DARA) with Bortezomib, Thalidomide, and Dexamethasone (VTd) in Transplant-Eligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) Negativity in Cassiopeia Part 1 and Part 2

Up-front carfilzomib, lenalidomide, and dexamethasone with transplant for patients with multiple myeloma: the IFM KRd final results

Multicentric Real Life Evaluation of the Impact of Next-Generation Sequencing on the Clinical Management of Chronic Myeloid Malignancies

Comparison of the Performance of Surface Alone or Surface Plus Cytoplasmic Approaches for the Assessment of Minimal Residual Disease in Multiparameter Flow Cytometry in Multiple Myeloma

Profound Lymphopenia at the Time of ATG Administration Is Not Predictive of Survivals after Allotransplant Using Purine Analogue/Busulfan-Based Conditioning Regimen

A New Cytokine-Based Stratification Is Highly Predictive of Survivals in AML Patients

Prognostic Value of Lymphopenia and Lymphocytosis after Peripheral Blood Haplo-Identical Stem Cell Transplantation

Fms-like Tyrosine Kinase 3 Ligand Concentration Kinetic Profile during Induction Is Strongly Predictive of Survivals in AML: Results of the FLAM/Flal Study

CD38 Expression in B-Lineage Acute Lymphoblastic Leukemia, a Possible Target for Immunotherapy

Expansion of T or B Lymphocytes after Unrelated Cord Blood (UCB) Allogeneic Stem Cell Transplantation in Adults Correlates with CMV Reactivation and Is Associated with a Better Outcome

Misleading acute promyelocytic leukemia morphology

Relative Stability Of Plasma Cells Immunophenotype In Multiple Myeloma Over Time

Cereblon (CRBN) Splicing Could Influence Response To IMiDs : A New PCR Strategy to Easily Detect and Semi-Quantify Loss Of The IMiDs Binding Domain

Paired Immunophenotype Comparison Of Diagnosis and Relapse Samples In B-Lineage Acute Lymphoblastic Leukemia

Backtracking Subclonal Mutations Of TP53 In Myelodysplasia (MDS) With Del(5q) With Next-Generation Sequencing (NGS)

Bortezomib, Lenalidomide, and Dexamethasone (VRD) Consolidation and Lenalidomide Maintenance in Frontline Multiple Myeloma Patients: Updated Results of the IFM 2008 Phase II VRD Intensive Program

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only